Sparfloxacin

CHEMBL850 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

392.4 g/mol

LogP

0.1

Phase

4

A fluoroquinolone antibiotic that kills bacteria by interfering with their DNA replication machinery, used to treat respiratory and other serious infections. Its use has become limited due to photosensitivity reactions and the potential to prolong the QT interval in the heart, raising arrhythmia concerns.

分子量

392.4000 g/mol

LogP

0.10

TPSA

98.90 Å²

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1

InChI

InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+

Molecular Formula

C19H22F2N4O3

HBD / HBA

3 / 9

回転可能結合数

3

重原子数

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A fluoroquinolone antibiotic that kills bacteria by interfering with their DNA replication machinery, used to treat respiratory and other serious infections. Its use has become limited due to photosensitivity reactions and the potential to prolong the QT interval in the heart, raising arrhythmia concerns.

Yes, Sparfloxacin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL850. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 60464. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Sparfloxacin PillFYIで

構造

クイックデータ

分子式: C19H22F2N4O3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.